Catalytic Asymmetric Total Synthesis of ent-Hyperforin
Catalytic Asymmetric Total Synthesis of ent-Hyperforin
复制标题
DOI:
10.1002/anie.200906678
复制
发表时间:
2010-01-01
影响因子:
16.6
通讯作者:
Shibasaki, Masakatsu
中科院分区:
文献类型:
--
作者:
Shimizu, Yohei;Shi, Shi-Liang;Shibasaki, Masakatsu
Naturally occurring polycyclic polyprenylated acylphloroglucinols (PPAPs: Scheme 1) commonly have a highly substituted bicyclo [3.3. 1] nonanone core.[1] Hyperforin (1), a representative of this family, was isolated from the herb St. John s wort (Hypericum perforatum).[2a] Hyperforin exhibits various biological activities, including mild antidepressant activity,[3] antimalarial activity,[4] human histone deacetylase inhibitory activity,[5] and CYP3A4 induction activity.[6] Enhancement of a specific biological activity through structural modification is an important direction in drug-discovery research, and thus establishing a flexible, asymmetric total synthetic route is a fundamental prerequisite.Their structural complexity and potential utility as pharmaceutical leads make PPAPs very attractive synthetic targets. The total syntheses of garsubellin A (2),[7] clusianone (3),[8] and nemorosone (4)[8d] have been accomplished.[9] The use of elegant biomimetic approaches to construct the bicyclic core has resulted in some of these racemic syntheses being short and applicable for the production of structurally diverse analogues.[8b, e, 9e] The catalytic asymmetric synthesis of PPAPs, however, remains a daunting challenge; there is only one asymmetric synthesis of PPAPs (that of 3), which involved a late-stage kinetic resolution using a stoichiometric amount of chiral lithium amide.[8c] Hyperforin (1) contains an additional chiral quaternary center at C8 compared to 2–4, thus